Key features
An investment approach which is backed by data and science, removing emotional biases inherent in stock picking
A diversified portfolio focused on high quality companies with strong and growing dividends
Aims to consistently deliver returns in excess of the benchmark through various market conditions
Daily pricing
as of
11/22/2024
NAV 1-day net change
0.28
Total net assets
as of
10/31/2024
All share classes
$693.9 million
Overview
Series identifiers |
CUSIP |
246493472 |
Benchmark
Portfolio
Market cap (median) Source: FactSet
$70.9 billion
Market cap (weighted average) Source: FactSet
$210.8 billion
Portfolio turnover (last fiscal year)
31%
International equities & depositary receipts
3.6%
Cash, cash equivalents and other assets
1.3%
Top 10 holdings
as of 10/31/2024
Holdings are as of the date indicated and subject to change.
List may exclude cash and cash equivalents. Please see the Series' complete list of holdings for more information.
Holdings based by issuer.
PHILIP MORRIS INTERNATIONAL INC
5.16
BRISTOL-MYERS SQUIBB CO
3.51
VERIZON COMMUNICATIONS INC
2.61
PNC FINANCIAL SERVICES GROUP INC (THE)
2.48
Total % Portfolio in Top 10 holdings - 36.24%
Sector allocation
as of 10/31/2024
List may exclude cash, cash equivalents, and exchange-traded funds (ETFs) that are used for cash management purposes. Please see the Series’ complete list of holdings for more information.
Information technology
11.9%
Communication services
11.7%
Consumer discretionary
6.7%
Management
Benjamin Leung, CFA
-
Managing Director, Head of Systematic Investments, Portfolio Manager
-
Start date on the Fund:
January 2021
-
Years of industry experience:
22
-
Read bio
Benjamin Leung
Managing Director, Head of Systematic Investments, Portfolio Manager
- Joined Macquarie in 2001
- Based in Sydney
Ben is the Head of the Macquarie Systematic Investments Team, a role he assumed in August 2024 after serving as Co-Head since August 2014. He is responsible for the day-to-day management of the global portfolios, oversight of the trading function, development of new strategies, and client engagement.
Prior to November 2023, Ben was also the Head of Research, responsible for setting the research agenda to drive the ongoing evolution of investment techniques and technology.
During his tenure with the firm, he has held roles in software development, quantitative research, and portfolio management for a range of Australian, Developed, and Emerging Markets Equity strategies.
He earned a Bachelor of Engineering (Honours) in software engineering (First Class) and a Master of Commerce in finance from the University of New South Wales. He holds the Chartered Financial Analyst® designation and he is a member of the CFA Institute.
Samir Vanza, CFA
-
Senior Vice President, Head of Quantitative Research, Portfolio Manager
-
Start date on the Fund:
August 2024
-
Years of industry experience:
19
-
Read bio
Samir Vanza
Senior Vice President, Head of Quantitative Research, Portfolio Manager
- Joined Macquarie in 2014
- Based in Sydney
Samir is Head of Quantitative Research for the Macquarie Systematic Investments (MSI) Team, a role he assumed in November 2023. In this capacity, Samir is responsible for setting the research agenda of the MSI Team as well as overseeing the development and maintenance of existing systematic models for the MSI Team’s global equity portfolios. Prior to November 2023, he was a Senior Quantitative Analyst on the MSI Team.
Before joining Macquarie, Samir worked as an Investment Analyst within the Asset Management team at Insurance Australia Group. In this role, he developed quantitative-based trading models and was involved in the monitoring and construction of investment portfolios.
Samir completed his Bachelor of Business (Honours) at the University of Technology Sydney and completed a Post Graduate Diploma in Applied Statistics from Macquarie University. He holds the Chartered Financial Analyst® designation and is a member of the CFA Institute.
Fees
The following table describes the fees and expenses that you may pay if you buy, hold,
and sell shares of the Series. The fee table does not reflect any fees or sales charges
imposed by variable insurance contracts. If it did, the expenses would be higher.
Annual portfolio operating expenses |
Management fees |
0.65% |
Distribution and service (12b-1) fees |
none |
Other expenses |
0.10% |
Total annual series operating expenses |
0.75% |
Fee waivers and expense reimbursements1 |
(0.03%) |
Total annual series operating expenses after fee waivers and expense reimbursements |
0.72% |
Please see the prospectus and SAI for additional information.
1Net expense ratio reflects a contractual waiver of certain fees and/or expense
reimbursements from May 1, 2024 through April 30, 2025. Please see the fee table in the Series'
prospectus for more information.
Resources
Shareholder report – Annual
Shareholder report – Semi-annual